The Living with Dementia (LiD) supports and promote post-graduate research in dementia care. Its research programme is designed to tackle the stigma and marginalisation of people with dementia, enhance practice and service provision and ultimately improve quality of life for people with dementia.
Research
DRNI Members Research is a list of ongoing and completed research carried out by DRNI members.
You can search via project type, disease, or Principal Investigator/Researcher name.
Search
Research type
Disease area
Project Aim(s): To support national and local Parkinson’s disease service planning by three linked work packages.
The first maps the prevalence of Parkinson’s disease and service availability for people with Parkinson’s, across each of the nine Community Healthcare Organisation regions in Ireland, to highlight mismatches between population needs and service provision.
Project Aim(s): To investigate bone morphogenetic protein 2 as a therapeutic for Parkinson's disease (PD).
NEIL is an umbrella programme, comprised of several large-scale research initiatives that look for new ways to enhance cognitive function in older adults and to delay or prevent dementia in at risk populations. Research projects include RelAte: A relationship-based mealtime intervention for older adults living alone, CST, the development of a Caregiver Support Tool and the development of a range of educational resources for academics, health practitioners and members of the general public.
NEIL is an umbrella programme, comprised of several large-scale research initiatives that look for new ways to enhance cognitive function in older adults and to delay or prevent dementia in at risk populations. Research projects include RelAte: A relationship-based mealtime intervention for older adults living alone, CST, the development of a Caregiver Support Tool and the development of a range of educational resources for academics, health practitioners and members of the general public.
Project Aim(s):
The project has various complementary aims: (a) research on normal ageing and Alzheimer's disease using MRI-based methods, (b) develop training programmes in neuroimaging in dementia, (c) develop greater understanding of the use of neuroimaging by clinicians for diagnosis of Alzheimer's disease, (d) technology transfer between centres.
NILVAD is a European multicentre double-blind placebo-controlled phase III trial of nilvadipine in mild to moderate Alzheimer’s disease. It represents 17 partners from 11 different countries and 23 different clinical trial sites. This 5 year double-blind placebo controlled study will test the efficacy and safety of nilvadipine in 500 subjects with mild to moderate AD over a treatment period of 18 months
Project Aim(s): To test a software engine designed to optimize medication in multimorbid older patients aimed at preventing unplanned hospitral readmissions.
Project Aim(s): PD-MitoQUANT is an Innovative Medicines Initiative (IMI)Innovative Medicines Initiative (IMI) (www.imi.europa.eu) project that brings together academic experts, small and medium enterprises (SMEs), pharmaceutical companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA)European Federation of Pharmaceutical Industries and Associations (EFPIA) (www.efpia.eu) and patient advocacy organisation Parkinson’s UKParkinson’s UK (www.p
